Spero Therapeutics
SPRO
SPRO
52 hedge funds and large institutions have $56M invested in Spero Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
50% less capital invested
Capital invested by funds: $113M → $56M (-$57M)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.43M | |
| 2 | +$1.04M | |
| 3 | +$486K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$214K |
| 5 |
Renaissance Technologies
New York
|
+$190K |
Top Sellers
| 1 | -$9.38M | |
| 2 | -$3.97M | |
| 3 | -$2.38M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$797K |